Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05761743

Glycemic Control, Type II Diabetes, Parathyroidectomy

Conditions: Primary Hyperparathyroidism, Type 2 Diabetes

Sex: All
Ages: 18 Years – N/A
Enrollment: 80
Sponsor: The Cleveland Clinic

Location: United States

Summary

The purpose of this study is to assess glycemic control after parathyroidectomy in patients with primary hyperparathyroidism and concomitant type 2 diabetes mellitus.

Eligibility Criteria

Inclusion Criteria:Study group: Consecutive patients older than 18 years old with concomitant PHPT and DM who will undergo PTX. The indications and need for surgery will be independent from the research team.Control group: Consecutive patients older than 18 years old with concomitant PHPT and DM who will not undergo PTX. The indications to forgo surgery will be independent from the research team.Exclusion Criteria:Patients with recurrent or persistent PHPT will not be included.Patients who are included but have evidence of recurrent or persistent PHPT based on six-month laboratory workup will be excluded from the final analysis (<5% expected)9.Patients with type 1 diabetes mellitusPatients with secondary and/or tertiary hyperparathyroidism

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05761743). StuddyBuddy aggregates publicly available trial information.